Paul A. Mahon, EVP & GENERAL COUNSEL at UNITED THERAPEUTICS Corp (UTHR), sold 8,300 shares at $555.72 ($4.7M) on 2026-05-21, disclosed to the SEC on 2026-05-21.
Scheduled sale ($4.7M) by EVP & GENERAL COUNSEL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $555.72 | 110 | $61K | 1.3% |
| 2 | $556.70 | 10 | $6K | 0.1% |
| 3 | $557.85 | 640 | $357K | 7.6% |
| 4 | $559.99 | 200 | $112K | 2.4% |
| 5 | $561.99 | 2,178 | $1.2M | 26.2% |
| 6 | $562.50 | 300 |
| $169K |
| 3.6% |
| 7 | $562.93 | 1,326 | $746K | 16.0% |
| 8 | $564.06 | 2,015 | $1.1M | 24.3% |
| 9 | $565.20 | 1,251 | $707K | 15.1% |
| 10 | $566.05 | 270 | $153K | 3.3% |
| Total | $562.82 avg | 8,300 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-09-03 | $4.0M | — | Filing → |
| UTHR | SELL | 2026-08-21 | $4.3M | — | Filing → |
| UTHR | SELL | 2026-08-06 | $4.3M | — | Filing → |